to support H.R. 1801, which covers oral chemotherapy the same way as IV chemotherapy.

Under current law, most IV treatments are routinely covered under the medical benefit component of a health insurance plan, while orally-administered anti-cancer medications are usually covered under the prescription drug component, which often results in a considerable disparity in coverage. This legislation would remove this disparity, ensuring that medication cost is not a factor in patient decisions. This is especially important as oral chemotherapy is becoming a more common standard of care for cancer patients and many of these oral chemotherapy drugs do not have IV/injectable equivalents. (http://higgins.house.gov/2013/05/rep-higgins-announces-introduction-of-c...)